FDA Approves New AndroGel Formulation
The FDA has approved Abbott's AndroGel 1.62%, a testosterone gel that restores levels of the hormone in hypogonadal men with half the volume of gel at the starting dose than delivered in AndroGel 1%.
The newly approved formulation contains 40.5 mg of testosterone in two pump presses, compared with the 1% gel's 50 mg in four pump presses.
With different dosage and administration instructions, the two gels are not interchangeable.
